COVID vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
A total of 1,800 adult volunteers will be needed for the trial.
Commentary
Why Hong Kong’s retail product reshuffle may favour large suppliers
Hong Kong hospitality: Momentum and the new lifestyle era
Understanding Hong Kong’s new land premium policy